Skip to content
Search AI Powered

Latest Stories

Blunt Take: Athletic Cannabis Bans and the Big Pharma Influence

Is Big Pharma behind WADA's cannabis ban? Probably.
Is Big Pharma behind WADA's cannabis ban? Probably.
Image by Gerhard from Pixabay

The World Anti-Doping Agency (WADA) has kept cannabis on its list of banned substances for 2023.

The list was finalized on Sept 23.


According to the Wall Street Journal, “WADA’s Prohibited List Expert Advisory Group has backed keeping a ban in place, saying that based on the scientific evidence available, the drug meets the criteria for inclusion on the list.”

WADA, which handles athletic drug testing for the Olympics and other sports, was urged by the U.S. Anti-Doping Agency last year to review its approach to cannabis after the controversial suspension of American sprinter Sha’Carri Richardson last year.

Richardson was suspended from participating in the Tokyo games after previously consuming cannabis in Oregon, where the plant has been medically legal since 1998 and legal for all adults since 2014.

In response to the outcry, WADA promised to initiate a scientific review of cannabis and is now leaning toward a continued ban.

But why? What scientific evidence did they review exactly?

What’s the concern with athletes using cannabis as part of their regimen?

Is Weed a Performance-Enhancing Substance?

The whole point of WADA’s existence is to prevent cheaters from spoiling the competition.

This message is loud and clear on the homepage of their website: “Raising the game for clean sport.”

Do they then consider cannabis as a performance enhancer? What other reason to ban it?

It’s not uncommon to hear of creatives getting dialed in at work with just the right dose of cannabinoids, or athletes enjoying invigorated exercise routines with improved recovery time thanks to cannabis’s anti-inflammatory properties.

Or what about athletes governed under WADA’s policies who could use cannabis to help with sleep, stress, and anxiety?

This doesn’t sound like a performance-enhancing drug at all because an optimized cannabis regimen is all about restoring balance and harmony to the body and the mind.

Imagine if WADA banned nutritional supplements. Imagine if they banned meditation. Sounds extreme right? Or what if they banned antidepressants or anti-inflammatories?

What’s wrong with an athlete who can learn how to use cannabis to take better care of themselves and maybe even improve the longevity of their career?

Frankly, this is a win-win scenario unless you’re Big Pharma still trying to peddle pill-shaped solutions.

The Big Pharma Factor

WADA’s Prohibited List Expert Advisory Group is heavily comprised of people who come from Big Pharma.

You can double check the group members over at WADA’s website for yourself. Even group chair Dr. Audrey Kinahan has a robust background in the pharmaceutical industry.

What’s more, they don’t consider cannabis a performance enhancer at all. It’s just a banned substance. In fact, athletes can get a Therapeutic Use Exemption (TUE) for it.

It’s no secret that Big Pharma has a vested interest in cannabis prohibition.

Over the years, Big Pharma has actively played a role in slowing cannabis progress through legislative lobbying (aka legalized bribery) and the funding of anti-cannabis propaganda.

Why would people want pills with harsh side effects when the right amount of cannabis at the right time seems to do a better job?

It was recently reported that the pharmaceutical industry is losing billions to the cannabis space, and they’re no doubt scratching and clawing out of sheer self-preservation.

When you consider how the industry’s business model relies on people getting or staying sick, how can you trust anything with their fingerprints on it?

Banning and Testing for THC is Problematic and Unfair

WADA’s continued ban of cannabis shows how little they care about science or the health of athletes.

“The problem with the testing of ‘marijuana’ (or THC) versus other substances is the duration of time in which is it detectable,” said Codi Peterson, Chief Science Offer at The Cannigma.

“Many drugs are long gone compared to THC metabolites which can linger for a while.”

In other words, weed can stay in your system for a long time, and you can still fail a drug test even if you haven’t consumed any THC for a few days, or sometimes longer.

And even then, does it really make sense to be testing for THC/cannabis in the first place?

“It’s cruel to expect athletes to perform for others’ entertainment, and not allow them to recover with humane treatments. WADA is shameful,” said Mara Gordon, founder of Aunt Zelda’s, which has helped thousands of chronically ill patients and their doctors integrate medical cannabis regimens into conventional treatment protocols.

Diana McElroy, a lifestyle wellness coach and yoga instructor also chimed in with her experience. “Cannabis is a medicine and helps people with inflammation and body aches. Athletes in particular benefit greatly.”

Of course, WADA will need more than just anecdotal reports to make an informed decision to lift the ban on cannabis.

But what info are they looking for exactly, other than Big Pharma stock ratings?

Need a little more Bluntness in your life? Subscribe for our newsletter to stay in the loop.

More For You

Traveling with cannabis? Read this article first.
Traveling with cannabis? Read this article first.

Cannabis and New York Airports? Here’s What Travelers Need To Know

Flying out of New York with your personal cannabis stash? Relax.

According to an article published by the Times Union, New York airport security checkpoints are no longer seizing cannabis.

Keep ReadingShow less
Financial Relief for NY Cannabis Farmers via $128 million Senate Plan
Financial Relief for NY Cannabis Farmers via $128 million Senate Plan

Relief Initiatives Offer Hope to Struggling New York Cannabis Farmers

The cannabis industry in New York is at a crossroads, with farmers grappling with a host of challenges amidst the slow rollout of dispensaries. Grateful Valley Farm, a woman-owned cannabis business in Steuben County, embodies the struggles faced by growers across the state.

Founder and CEO Tess Interlicchia, driven by her medical background, entered the cannabis industry with a passion to provide healing through the plant. However, regulatory hurdles and market constraints have left farmers like Interlicchia facing financial uncertainty.

Keep ReadingShow less
What's Going on With New York's Legal Cannabis Rollout
What's Going on With New York's Legal Cannabis Rollout

What’s Going on with New York’s Legal Cannabis Roll Out? 

The New York cannabis industry is facing a complex and challenging landscape as it transitions from a medical marijuana program to a fully legal recreational market. Despite the recent legalization of adult-use cannabis in the state, there are still many issues to be addressed, including regulatory compliance, licensing, distribution, capital and equity concerns, and of course, litigation.

Recently, several lawsuits have been filed against the New York State Cannabis Control Board (CCB) and the Office of Cannabis Management (OCM), which are the agencies responsible for overseeing the state's cannabis industry.

Keep ReadingShow less
Apparently past weed crimes can still be used against you in New Jersey.
Apparently past weed crimes can still be used against you in New Jersey.
Image by Gerd Altmann from Pixabay

Why is New Jersey Still Penalizing People for Weed?

When Governor Phil Murphy signed a suite of laws to legalize adult-use cannabis in New Jersey, he was vocal about the state’s plan of action, ensuring the legislation would reflect the industry’s blatant need for equity, expungement, and long overdue justice for the victims of the country’s War on Drugs.

The state’s court seemed to initially stay true to their word, expunging over 360,000 cannabis convictions within the first few months of legalization. 

Keep ReadingShow less
New York's OCM Delivers Big Improvements on Cannabis Regulations
New York's OCM Delivers Big Improvements on Cannabis Regulations

Big News From NY's Office Of Cannabis Management (OCM) On Regulations

In an exciting development for New York’s burgeoning yet hobbled cannabis industry, the Office of Cannabis Management (OCM) has released a set of revised regulations that will shape the future of cannabis businesses in the state. 

These new regulations bring about significant, yet much needed changes to licensing, co-location, compensation arrangements, purchasing limits, and consumption areas, offering both opportunities and clarity for NY’s cannabis entrepreneurs and consumers alike.

Keep ReadingShow less